tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Morning News Wrap-Up: Monday’s Biggest Stock Market Stories
PremiumMarket NewsMorning News Wrap-Up: Monday’s Biggest Stock Market Stories
1M ago
Adaptimmune Announces CCO Departure and Severance Agreement
Premium
Company Announcements
Adaptimmune Announces CCO Departure and Severance Agreement
1M ago
Hold Rating Maintained for Adaptimmune Therapeutics Amid Revenue Growth and Strategic Uncertainties
Premium
Ratings
Hold Rating Maintained for Adaptimmune Therapeutics Amid Revenue Growth and Strategic Uncertainties
2M ago
Hold Rating Maintained for Adaptimmune Therapeutics Amid Strategic Asset Sale and Leadership Changes
PremiumRatingsHold Rating Maintained for Adaptimmune Therapeutics Amid Strategic Asset Sale and Leadership Changes
2M ago
Adaptimmune downgraded to Neutral from Buy at Guggenheim
Premium
The Fly
Adaptimmune downgraded to Neutral from Buy at Guggenheim
2M ago
Adaptimmune downgraded to Neutral from Buy at H.C. Wainwright
Premium
The Fly
Adaptimmune downgraded to Neutral from Buy at H.C. Wainwright
2M ago
Adaptimmune downgraded to Neutral from Outperform at Mizuho
PremiumThe FlyAdaptimmune downgraded to Neutral from Outperform at Mizuho
3M ago
Adaptimmune’s Annual Meeting Focuses on Shareholder Engagement
Premium
Company Announcements
Adaptimmune’s Annual Meeting Focuses on Shareholder Engagement
4M ago
Hold Rating for Adaptimmune Therapeutics Amid Strategic Progress and Financial Uncertainties
Premium
Ratings
Hold Rating for Adaptimmune Therapeutics Amid Strategic Progress and Financial Uncertainties
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100